Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer by Philippa R. Kennedy, Martin Felices, Jeffrey S. Miller

Get full text

HLA-B and HLA-C Differ in Their Nanoscale Organization at Cell Surfaces by Philippa R. Kennedy, Charlotte Barthen, Charlotte Barthen, David J. Williamson, Daniel M. Davis

Get full text

The Size of Activating and Inhibitory Killer Ig-like Receptor Nanoclusters Is Controlled by the Transmembrane Sequence and Affects Signaling by Anna Oszmiana, David J. Williamson, Shaun-Paul Cordoba, David J. Morgan, Philippa R. Kennedy, Kevin Stacey, Daniel M. Davis

Get full text

365 Oxygen levels found in bone marrow (5%) provide an optimal niche for the differentiation of induced-pluripotent stem cell-derived NK cells for the treatment of AML by Jeffrey S Miller, Bahram Valamehr, Behiye Kodal, Martin Felices, Peter Hinderlie, Laura Bendzick, Carly Selleck, Philippa R Kennedy, Quinlan M Kile, Rhett L Waller, Marissa Kaufman

1180 Maximizing NK cell immunotherapy in prostate cancer via TriKEs by Joshua Walker, Jeffrey S Miller, Nicholas Zorko, Martin Felices, Peter Hinderlie, Shee Kwan Phung, Laura Bendzick, Yvette Soignier, Madison Shackelford, Asha Bozicevich, Carly Selleck, Trygve Nelson, Philippa R Kennedy

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer by Philippa R. Kennedy, Daniel A. Vallera, Brianna Ettestad, Caroline Hallstrom, Behiye Kodal, Deborah A. Todhunter, Laura Bendzick, Peter Hinderlie, Joshua T. Walker, Brittany Pulkrabek, Ira Pastan, Robert A. Kratzke, Naomi Fujioka, Jeffrey S. Miller, Martin Felices

Get full text

NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer by Elaine Y.L. Leung, Darren P. Ennis, Philippa R. Kennedy, Christopher Hansell, Suzanne Dowson, Malcolm Farquharson, Pavlina Spiliopoulou, Jaya Nautiyal, Sophie McNamara, Leo M. Carlin, Kerry Fisher, Daniel M. Davis, Gerard Graham, Iain A. McNeish

Get full text